Botanix Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	31.61	64.97	79.31	10.25	7.29	21.55
Cash & Short-Term Investments	31.61	64.97	79.31	10.25	7.29	21.55
Cash Growth	-34.73%	-18.08%	673.71%	40.69%	-66.20%	-12.54%
Accounts Receivable	5.7	2.85	0.46	0.4	-	-
Other Receivables	-	0.35	0.36	0.09	0.14	0.05
Receivables	5.7	3.2	0.82	0.49	0.14	0.05
Inventory	27.51	28.08	1.21	3.15	3.04	-
Prepaid Expenses	5.91	3.34	0.1	0.09	0.03	0.01
Other Current Assets	-	-	1.47	-	-	-
Total Current Assets	70.74	99.59	82.9	13.98	10.5	21.61
Property, Plant & Equipment	1.13	1.38	0.07	0.07	0.18	0.28
Other Intangible Assets	26.71	28.12	29.49	6.86	3.3	-
Long-Term Deferred Charges	-	-	-	3.87	-	-
Other Long-Term Assets	-	-	-	0.06	0.06	0.06
Total Assets	98.57	129.1	112.46	24.84	14.04	21.95
Accounts Payable	7	8.87	2.73	1.39	4.68	0.65
Accrued Expenses	4.28	3.94	0.56	0.15	0.1	0.09
Current Portion of Leases	0.46	0.41	-	-	0.12	0.15
Other Current Liabilities	15.93	11.7	0.44	0.34	0.99	0.15
Total Current Liabilities	27.66	24.92	3.73	1.88	5.89	1.04
Long-Term Leases	0.62	0.81	-	-	-	0.11
Other Long-Term Liabilities	16.29	22.07	-	-	-	-
Total Liabilities	44.58	47.8	3.73	1.88	5.89	1.15
Common Stock	226.32	226.3	188.32	93.49	71.48	71.48
Retained Earnings	-210.38	-177.19	-90.79	-76.92	-67.77	-54.6
Comprehensive Income & Other	38.06	32.18	11.2	6.38	4.44	3.92
Shareholders' Equity	54	81.3	108.73	22.95	8.15	20.8
Total Liabilities & Equity	98.57	129.1	112.46	24.84	14.04	21.95
Total Debt	1.08	1.22	-	-	0.12	0.26
Net Cash (Debt)	30.53	63.75	79.31	10.25	7.16	21.3
Net Cash Growth	-35.81%	-19.62%	673.71%	43.10%	-66.36%	-12.09%
Net Cash Per Share	0.02	0.03	0.05	0.01	0.01	0.02
Filing Date Shares Outstanding	1,968	1,961	1,814	1,421	1,085	973.14
Total Common Shares Outstanding	1,968	1,961	1,810	1,312	973.14	973.14
Working Capital	43.08	74.67	79.17	12.09	4.62	20.57
Book Value Per Share	0.03	0.04	0.06	0.02	0.01	0.02
Tangible Book Value	27.29	53.17	79.24	16.1	4.86	20.8
Tangible Book Value Per Share	0.01	0.03	0.04	0.01	0.00	0.02

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.